ACS

9 drugs in development·8 companies·1 clinical trial

Drug Pipeline by Phase

Approved(7)

Drug	Company
clopidogrel bi	Teva Pharmaceutical Industries Limited (TEVA)
clopidogrel bi	DR REDDYS LABORATORIES LTD (RDY)
ticagrelor	DR REDDYS LABORATORIES LTD (RDY)
ticagrelor	Mylan II B.V. (MYL)
ticagrelor	Amneal Pharmaceuticals, Inc. (AMRX)
tirofiban	NEXUS BIOPHARMA INC (NEXS)
unloxcyt	Fortress Biotech Inc. (FBIO)

Phase 3(1)

Drug	Company
pelacarsen	Novartis AG (NVS)

Preclinical(1)

Drug	Company
Cannabics SR	CNBX Pharmaceuticals Inc. (CNBX)

BioSniper tracks 9 drugs in development for ACS across 8 companies.

There are 1 clinical trial targeting ACS tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.